Company

Sujal Patel is a successful technology entrepreneur and executive who founded and served as CEO of Isilon Systems, an enterprise data storage company. In 2006, Isilon completed one of the most successful initial public offerings of the year. Isilon was acquired by EMC in 2010 for $2.6 Billion, the largest acquisition in EMC’s history. Sujal served as the President of EMC’s Isilon Storage Division from the acquisition until 2012, driving significant revenue growth, market expansion and organizational scale. He graduated from the University of Maryland College Park in 1996 with a degree in Computer Science.

Dr. Parag Mallick is an Associate Professor at Stanford University, and an interdisciplinary scientist, who has developed multi-scale approaches to accelerate the discovery of diagnostic and prognostic protein biomarkers. Parag trained with pioneering researcher Ruedi Aebersold in clinical proteomics and systems biology at the Institute for Systems Biology. Parag holds a BS degree in Computer Science from Washington University in St. Louis, and a PhD in Chemistry & Biochemistry from UCLA. He has over 100 publications and holds patents in the fields of artificial intelligence, proteomics technology, biomarker development, and nanotechnology.

Anna is an experienced finance and business leader who joins Nautilus from Igneous where she served as VP of Finance and Operations with responsibility for finance, accounting, people, legal, and operations. Previously, Anna held a variety of roles at companies including Amazon Web Services and Isilon Systems, where she ultimately led the finance and sales operations organization. Anna has a BS in Biochemistry from Western Washington University and started her career at the Fred Hutchinson Cancer Research Institute. She earned her MBA from the University of Washington, leading her into a variety of finance and business roles of escalating responsibility.

Nick Nelson has extensive leadership experience with top-tier diagnostics, therapeutics and life science companies. Before joining Nautilus, he was Chief Business Officer at Caris Life Sciences where he led all business development and strategic partnerships. Prior to Caris, he was Vice President of Commercial and Corporate Development at Trovagene (now Cardiff Oncology), and before that spent ten years at Illumina. While at Illumina he held leadership positions in the New and Emerging Markets business where he established partnerships and collaborations enabling high-growth genomics businesses. He received his Bachelor of Science degree in Cellular and Molecular Biology from San Diego State University.

Ken is a seasoned product and marketing leader who joins Nautilus from Agilent Technologies where he most recently served as Vice President and General Manager of Agilent’s Mass Spectrometry division. He held several leadership positions during his twenty-five years at Agilent, including Vice President of Global Marketing for CrossLab Services and Support, Vice President and General Manager of Strategic Program Office, and Agilent Certified Pre-Owned Instruments and Associate VP of Marketing in Spectroscopy. His track record in the life sciences and technology sector spans nearly three decades across marketing, strategic program management, finance, and research and development. Previously, he held roles in applications and sales at Takeda Pharmaceuticals in Tokyo, Japan, and in finance at Hewlett-Packard (HP) before contributing to the founding of Agilent. Ken received his M.B.A. from the Haas School of Business at the University of California, Berkeley, and his B.S. in Biological Engineering from Cornell University.

Gwen has more than 25 years of senior leadership in human resources, organizational culture, and business strategy. She previously held the positions of Vice President of Global People and Infrastructure at Isilon Systems for more than six years and General Manager of Human Resources at Microsoft Corporation for nearly twenty years, leading Microsoft’s human resources agenda for its various groups and overseeing worldwide recruiting and alternative staffing. Ms. Weld studied business administration at Pace University.

Subra is a seasoned product and engineering leader who joins Nautilus from GenapSys where he served as SVP of Product Development, leading the company’s R&D efforts including Engineering, Assay, System Integration, Consumable Development, Informatics and a variety of chemistry and molecular biology groups. Subra has held many senior roles over the last 15 years, notably at Solexa/Illumina where, from 2006 to 2012, he led instrument and consumable development efforts for next gen sequencers and related products. Subra has a Ph.D. in Aerospace Engineering from Georgia Tech and an MBA from UC Berkeley.

Matt has spent over a quarter century advising companies on the cutting edge of life sciences technologies. He has held numerous General Counsel roles over this period, including most notably at Pacific Biosciences and 10X Genomics. He specializes in creating and defending industry defining patent portfolios, and in building and leading legal operations that help develop, finance and commercialize high growth companies. Matt received his Bachelor of Science in Microbiology and Fermentation Science from the University of California, Davis, and a Juris Doctorate from the University of San Francisco School of Law.

Chris is a proven marketing leader who joins Nautilus from Smartsheet where he served as VP of Marketing and Communications with responsibility for creating markets, building awareness, and driving revenue. Prior to that, he led marketing and communications at ExtraHop Networks and Isilon Systems through the company’s acquisition by EMC. At EMC/Isilon, he served as executive sponsor of the company’s Life Sciences and Genomics markets, leading product evangelism, market research, and sales preparedness. Chris holds a BS from Syracuse University.

Martin brings to Nautilus over 20 years experience in biotechnology start-ups both in Europe and the US, most recently as founder, CTO and, ultimately, CEO of Quantapore, a company devoted to pioneering massively parallel, direct, single-molecule DNA and protein analytical tools. Prior to that, he held senior scientist positions at IonTorrent and Nanosphere. He holds an M.S. and Ph.D in Genetics and Biochemistry from the University of Vienna, Austria.

Sheri spent 21 years at SomaLogic where she was instrumental in the development of the SomaScan Platform and SOMAmer reagents. As Associate Director of Aptamer Discovery she guided research of aptamers for biomarker discovery and directed the high-throughput generation of SOMAmer reagents, and as Senior Director of Analytical and Discovery Sciences, led SOMAmer discovery and characterization efforts, as well as several collaborations. Before joining SomaLogic, she was a postdoctoral fellow at Pharmacia, prior to its merger with Pfizer Inc. Dr. Wilcox received her B.S. in chemistry from Vanderbilt University, and her Ph.D. in macromolecular and cellular structure and chemistry from Scripps Research.

Former SVP & Head of Sales, Illumina